SCHEMBL28628173

SCHEMBL28628173

[CH2]CCOc1ccc(C=O)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 5/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
POLB P06746 1/20 0.42
FDPS P14324 1/20 0.39
KCNJ1 P48048 1/20 0.36
MAPT P10636 3/20 0.35
APP P05067 2/20 0.35
SNCA P37840 1/20 0.35
SMN1; SMN2 Q16637 5/20 0.34
LMNA P02545 3/20 0.34
HPGD P15428 2/20 0.34
IDH1 O75874 1/20 0.34
HTT P42858 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28638782 0.85 ALDH1A1 (0.53) ALDH1A1KDM4EL3MBTL1POLBFDPS
SCHEMBL20489824 0.81 ALDH1A1 (0.54) ALDH1A1KDM4EL3MBTL1POLBFDPS
SCHEMBL20489821 0.81 KDM4E (0.54) ALDH1A1KDM4EL3MBTL1POLBFDPS
SCHEMBL245424 0.81 ALDH1A1 (0.50) ALDH1A1KDM4EL3MBTL1POLBFDPS
SCHEMBL29416984 0.81 ALDH1A1 (0.54) ALDH1A1KDM4EL3MBTL1POLBFDPS
SCHEMBL22223316 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EL3MBTL1POLBFDPS
SCHEMBL1943866 0.80 KDM4E (0.53) ALDH1A1KDM4EL3MBTL1POLBFDPS
SCHEMBL29611929 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EL3MBTL1POLBFDPS
SCHEMBL19952870 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EL3MBTL1POLBFDPS
SCHEMBL18810213 0.80 ALDH1A1 (0.53) ALDH1A1KDM4EL3MBTL1POLBFDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113454086-A Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR7 agonists 百济神州有限公司 2021-09-28 CN disclosed